Your browser doesn't support javascript.
loading
Targeting Podoplanin for the Treatment of Osteosarcoma.
Takemoto, Ai; Takagi, Satoshi; Ukaji, Takao; Gyobu, Nobuhiko; Kakino, Mamoru; Takami, Miho; Kobayashi, Asami; Lebel, Marie; Kawaguchi, Tokuichi; Sugawara, Minoru; Tsuji-Takayama, Kazue; Ichihara, Kenji; Funauchi, Yuki; Ae, Keisuke; Matsumoto, Seiichi; Sugiura, Yoshiya; Takeuchi, Kengo; Noda, Tetsuo; Katayama, Ryohei; Fujita, Naoya.
Afiliación
  • Takemoto A; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.
  • Takagi S; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.
  • Ukaji T; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.
  • Gyobu N; API Co., Ltd., Kanosakuradacho, Gifu-shi, Gifu, Japan.
  • Kakino M; API Co., Ltd., Kanosakuradacho, Gifu-shi, Gifu, Japan.
  • Takami M; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.
  • Kobayashi A; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.
  • Lebel M; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo, Japan.
  • Kawaguchi T; Project for Development of Genomics-based Cancer Medicine, Cancer Precision Medicine Center, JFCR, Koto-ku, Tokyo, Japan.
  • Sugawara M; Project for Development of Genomics-based Cancer Medicine, Cancer Precision Medicine Center, JFCR, Koto-ku, Tokyo, Japan.
  • Tsuji-Takayama K; API Co., Ltd., Kanosakuradacho, Gifu-shi, Gifu, Japan.
  • Ichihara K; API Co., Ltd., Kanosakuradacho, Gifu-shi, Gifu, Japan.
  • Funauchi Y; Department of Orthopedic Oncology, Cancer Institute Hospital, JFCR, Koto-ku, Tokyo, Japan.
  • Ae K; Department of Orthopedic Oncology, Cancer Institute Hospital, JFCR, Koto-ku, Tokyo, Japan.
  • Matsumoto S; Sarcoma Center, Cancer Institute Hospital, JFCR, Koto-ku, Tokyo, Japan.
  • Sugiura Y; Division of Pathology, Cancer Institute, JFCR, Koto-ku, Tokyo, Japan.
  • Takeuchi K; Division of Pathology, Cancer Institute, JFCR, Koto-ku, Tokyo, Japan.
  • Noda T; Department of Pathology, Cancer Institute Hospital, JFCR, Koto-ku, Tokyo, Japan.
  • Katayama R; Pathology Project for Molecular Targets, Cancer Institute, JFCR, Koto-ku, Tokyo, Japan.
  • Fujita N; Cancer Institute, JFCR, Koto-ku, Tokyo, Japan.
Clin Cancer Res ; 28(12): 2633-2645, 2022 06 13.
Article en En | MEDLINE | ID: mdl-35381070
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Glicoproteínas de Membrana / Osteosarcoma / Lectinas Tipo C / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Óseas / Glicoproteínas de Membrana / Osteosarcoma / Lectinas Tipo C / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón